USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Screening for Chronic Obstructive Pulmonary DiseaseUS Preventive Services Task Force Reaffirmation Recommendation Statement

To identify the key insights or developments described in this article
1 Credit CME
Abstract

Importance  Chronic obstructive pulmonary disease (COPD) is an irreversible reduction of airflow in the lungs. Progression to severe disease can prevent participation in normal activities because of deterioration of lung function. In 2020 it was estimated that approximately 6% of US adults had been diagnosed with COPD. Chronic lower respiratory disease, composed mainly of COPD, is the sixth leading cause of death in the US.

Objective  To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence update that focused on targeted key questions for benefits and harms of screening for COPD in asymptomatic adults and treatment in screen-detected or screen-relevant adults.

Population  Asymptomatic adults who do not recognize or report respiratory symptoms.

Evidence Assessment  Using a reaffirmation process, the USPSTF concludes with moderate certainty that screening for COPD in asymptomatic adults has no net benefit.

Recommendation  The USPSTF recommends against screening for COPD in asymptomatic adults. (D recommendation)

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Carol M. Mangione, MD, MSPH, David Geffen School of Medicine, University of California, Los Angeles, 1100 Glendon Avenue, Suite 900, Los Angeles, CA 90024 (chair@uspstf.net).

Accepted for Publication: March 31, 2022.

The US Preventive Services Task Force (USPSTF) members: Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Carlos Roberto Jaén, MD, PhD, MS; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; John M. Ruiz, PhD; James Stevermer, MD, MSPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.

Affiliations of The US Preventive Services Task Force (USPSTF) members: University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of North Carolina at Chapel Hill (Nicholson, Donahue); Albert Einstein College of Medicine, New York, New York (Cabana); Oregon Health & Science University, Portland (Caughey); Virginia Commonwealth University, Richmond (Chelmow); University of Washington, Seattle (Coker); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); University of Texas Health Science Center, San Antonio (Jaén); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); University of Arizona, Tucson (Ruiz); University of Missouri, Columbia (Stevermer); University of Hawaii, Honolulu (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).

Author Contributions: Dr Mangione had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.

Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.

Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.

Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.

Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.

Additional Contributions: We thank Brandy L. Peaker, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.

Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Published by JAMA®—Journal of the American Medical Association under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2022 AMA and United States Government, as represented by the Secretary of the Department of Health and Human Services (HHS), by assignment from the members of the United States Preventive Services Task Force (USPSTF). All rights reserved.

References
1.
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. Basics about COPD. Reviewed 2021. Accessed October 5, 2021. https://www.cdc.gov/copd/basics-about.html
2.
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS prevalence & trends data. 2020. Accessed February 24, 2022. https://nccd.cdc.gov/BRFSSPrevalence/rdPage.aspx?rdReport=DPH_BRFSS.ExploreByTopic&irbLocationType=StatesAndMMSA&islClass=CLASS03&islTopic=TOPIC14&islYear=2020&rdRnd=5282
3.
Centers for Disease Control and Prevention, National Center for Health Statistics. Deaths and mortality. Reviewed 2022. Accessed February 24, 2022. https://www.cdc.gov/nchs/fastats/deaths.htm
4.
Ahmad  FB , Anderson  RN .  The leading causes of death in the US for 2020.   JAMA. 2021;325(18):1829-1830. doi:10.1001/jama.2021.5469PubMedGoogle ScholarCrossref
5.
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. Chronic obstructive pulmonary disease (COPD) data and statistics. Reviewed 2021. Accessed October 5, 2021. https://www.cdc.gov/copd/data.html
6.
Laffey  KG , Nelson  AD , Laffey  MJ , Nguyen  Q , Sheets  LR , Schrum  AG .  Chronic respiratory disease disparity between American Indian/Alaska Native and white populations, 2011-2018.   BMC Public Health. 2021;21(1):1466. doi:10.1186/s12889-021-11528-8PubMedGoogle ScholarCrossref
7.
Wheaton  AG , Liu  Y , Croft  JB ,  et al.  Chronic obstructive pulmonary disease and smoking status—United States, 2017.   MMWR Morb Mortal Wkly Rep. 2019;68(24):533-538. doi:10.15585/mmwr.mm6824a1PubMedGoogle ScholarCrossref
8.
National Center for Health Statistics.  Health, United States, 2019. US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2021. doi:10.15620/cdc:100685
9.
Kuhn  BT , Wick  KD , Schivo  M .  An update in health disparities in COPD in the USA.   Curr Pulmonol Rep. 2021;10:14-21. doi:10.1007/s13665-021-00268-0Google ScholarCrossref
10.
US Preventive Services Task Force.  Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force recommendation statement.   JAMA. 2016;315(13):1372-1377. doi:10.1001/jama.2016.2638PubMedGoogle ScholarCrossref
11.
US Preventive Services Task Force. Procedure Manual. Updated May 2021. Accessed October 5, 2021. https://uspreventiveservicestaskforce.org/uspstf/procedure-manual
12.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Published 2022. Accessed February 24, 2022. https://goldcopd.org/2022-gold-reports-2/
13.
Lin  JS , Webber  EM , Thomas  RG .  Screening for Chronic Obstructive Pulmonary Disease: A Targeted Evidence Update for the US Preventive Services Task Force. Evidence Synthesis No. 215. Agency for Healthcare Research and Quality; 2022. AHRQ publication 21-05287-EF-1.
14.
Krist  AH , Davidson  KW , Mangione  CM ,  et al; US Preventive Services Task Force.  Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement.   JAMA. 2021;325(3):265-279. doi:10.1001/jama.2020.25019PubMedGoogle ScholarCrossref
15.
Owens  DK , Davidson  KW , Krist  AH ,  et al; US Preventive Services Task Force.  Primary care interventions for prevention and cessation of tobacco use in children and adolescents: US Preventive Services Task Force recommendation statement.   JAMA. 2020;323(16):1590-1598. doi:10.1001/jama.2020.4679PubMedGoogle ScholarCrossref
16.
Webber  EM , Lin  JS , Thomas  RG .  Screening for chronic obstructive pulmonary disease: updated evidence report and systematic review for the US Preventive Services Task Force.   JAMA. Published May 10, 2022. doi:10.1001/jama.2022.4708Google Scholar
17.
Guirguis-Blake  JM , Senger  CA , Webber  EM , Mularski  RA , Whitlock  EP .  Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US Preventive Services Task Force.   JAMA. 2016;315(13):1378-1393. doi:10.1001/jama.2016.2654PubMedGoogle ScholarCrossref
18.
Qaseem  A , Wilt  TJ , Weinberger  SE ,  et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society.  Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.   Ann Intern Med. 2011;155(3):179-191. doi:10.7326/0003-4819-155-3-201108020-00008PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close